Join
Live feed
·
INSIDERFilingvia Quantisnow
Context Therapeutics Inc. logo

SEC Form 4: Sahmoud Tarek bought $19,500 worth of shares (10,000 units at $1.95)

ByQuantisnow·Wall Street's wire, on your screen.
CNTX· Context Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTX (Context Therapeutics Inc.) and more on Quantisnow.